MIBHS

OCTOBER 31, 2024

Dilation: The chambers of the heart expand, making the walls thinner. Both forms of enlargement may compromise the heart’s ability to pump blood efficiently, leading to further complications like heart failure. What Causes an Enlarged Heart? Antiarrhythmics to help manage abnormal heart rhythms.

Blood Pressure 52

Blood Pressure Blood Clot Heart Valves Heart Rhythm 52

DAIC

APRIL 9, 2024

Decline in exercise ability is a hallmark of progression to overt heart failure. These results also speak to the importance of continuing to focus on earlier recognition of heart failure risk in patients with diabetes and on initiating treatment before the condition has progressed to overt heart failure.”

Heart Failure 52

Heart Failure Diabetes Cardiomyopathy Exercise 52

DAIC

JUNE 24, 2024

Kittleson, director of Heart Failure Research and director of Post Graduate Medical Education in Heart Failure and Transplantation, is an associate editor specializing in heart failure. She also has served on the board of directors of the Heart Failure Society of America.

Heart Failure 100

Heart Failure Transplant Interventional Cardiology Research 100

DAIC

JULY 29, 2024

Edwards anticipates FDA approval of the JenaValve Trilogy Heart Valve System in late 2025, which will represent the first approved therapy for patients suffering from AR. Building on an investment made in 2016, Edwards has exercised its option to acquire Endotronix , a leader in heart failure (HF) management solutions.

Innovation 105

Innovation Aortic valve Aortic CMS 105

DAIC

JUNE 11, 2024

Tricuspid and mitral valves are debilitating conditions that can lead to arrhythmias, hypertension, and heart failure. Until recently, therapeutic options for people with tricuspid and mitral valve disorders have been limited to symptom relief or high-risk surgery.

Tricuspid 111

Tricuspid Bicuspid/Mitral Heart Valves Innovation 111

DAIC

APRIL 9, 2024

Image courtesy of UC Davis Health milla1cf Tue, 04/09/2024 - 16:47 April 9, 2024 — UC Davis Health cardiology team members are among the first in the country to treat patients with tricuspid regurgitation , or a leaky heart valve, by using a groundbreaking catheter. Rogers , professor of cardiovascular medicine.

Tricuspid 111

Tricuspid Heart Valves Bicuspid/Mitral Quality of Life 111

Frontiers in Cardiovascular Medicine

FEBRUARY 10, 2025

Current smoker, hypertension, heart failure, previous myocardial infarction, cerebrovascular disease, CysC, and NT-proBNP were selected as independent risk factors for AKI. The risk prediction model was evaluated using receiver operating characteristic (ROC), calibration curve, and decision curve analysis (DCA).Results220

Heart Valves 40

Heart Valves Risk Factors Cerebrovascular Disease Myocardial Infarction 40

DAIC

FEBRUARY 18, 2025

Raj Makkar, MD: Tricuspid regurgitation is a condition where the tricuspid valve fails to close properly, allowing blood to flow backward into the right atrium. How has treatment for tricuspid valve disease evolved?

Tricuspid 52

Tricuspid Open-Heart Surgery Quality of Life Anatomy 52

American College of Cardiology

APRIL 26, 2024

Transcatheter mitral valve-in-ring (MViR) using third-generation balloon-expandable aortic transcatheter heart valves was associated with a significant reduction in mitral regurgitation (MR) and improvement in heart failure symptoms at one year, with the tradeoff of elevated valvular gradients and a high rate of reintervention, according to a recent (..)

Bicuspid/Mitral 53

Bicuspid/Mitral Heart Valves Cardiovascular Interventions Heart Failure 53

DAIC

MARCH 8, 2024

suffer from heart failure , and there are approximately 400,000 heart-failure-related deaths in this country each year. Patients with heart failure often experience reduced mobility, quality of life and ability to work; the disease also represents a significant public health care burden.

Blood Clot 98

Blood Clot Heart Failure Quality of Life Innovation 98

Frontiers in Cardiovascular Medicine

JANUARY 23, 2024

This study describes the changes in cognitive function associated with coronary artery disease, myocardial infarction, heart failure, atrial fibrillation and heart valve disease. An updated understanding of the two known pathogenic mechanisms of cardiogenic dementia is presented and discussed.

Dementia 64

Dementia Coronary Artery Disease Quality of Life Myocardial Infarction 64

Frontiers in Cardiovascular Medicine

OCTOBER 7, 2024

BackgroundEmerging evidence indicates a significant link between various immune cell types and the development of heart valve disorders. Mitral valve prolapse (MVP) is a common condition that can lead to heart failure, arrhythmias, and even sudden death.

Bicuspid/Mitral 59

Bicuspid/Mitral Heart Valves Heart Failure Arrhythmia 59

DAIC

JANUARY 16, 2024

Shreenivas is a frequent speaker at major scientific meetings and has been widely published in peer-reviewed journals across the structural heart, heart failure, and coronary arenas. The Carillon Mitral Contour System is designed to treat both FMR and heart failure in one simple, short, minimally-invasive procedure.

Bicuspid/Mitral 59

Bicuspid/Mitral Heart Failure Catheterization Laboratory Innovation 59

DAIC

APRIL 23, 2024

When the valve narrows, it does not open or close properly, making the heart work harder to pump blood throughout the body. Eventually, this causes the heart to weaken and function poorly, which may lead to heart failure and increased risk for sudden cardiac death. Presented at Heart Valve Society 2024, Boston, MA.

Aortic valve 111

Aortic valve Aortic Innovation Cardiothoracic 111

DAIC

JUNE 13, 2024

When the valve narrows, it does not open or close properly, making the heart work harder to pump blood throughout the body. Eventually, this causes the heart to weaken and function poorly, which may lead to heart failure and increased risk for sudden cardiac death. Presented at Heart Valve Society 2024, Boston, MA.

Aortic valve 109

Aortic valve Aortic Innovation Cardiothoracic 109

DAIC

JUNE 11, 2024

Tricuspid and mitral valves are debilitating conditions that can lead to arrhythmias, hypertension, and heart failure. Until recently, therapeutic options for people with tricuspid and mitral valve disorders have been limited to symptom relief or high-risk surgery.

Tricuspid 52

Tricuspid Bicuspid/Mitral Heart Valves Innovation 52

DAIC

JUNE 12, 2024

Additionally, the company also offers the first fully automated 3D quantification of mitral regurgitation (MR) volumes* designed to provide reproducible, efficient analysis helps clinicians make better-informed decisions for patients with heart valve disease. “As

Ultrasound 105

Ultrasound Cardio Oncology Technology Congenital Heart Disease 105

Global Cardiac Surgery

AUGUST 19, 2018

million people suffer from rheumatic heart disease (RHD), with an additional 47 million living with asymptomatic damage to their heart valves, as a result of earlier acute rheumatic fever. RHD is the most commonly acquired heart disease for people under 25 years old and over 1.2 Although largely preventable, 33.4

Heart Disease 52

Heart Disease Bicuspid/Mitral Health Disparities Heart Failure 52

European Journal of Heart Failure

FEBRUARY 19, 2024

Rates of concomitant tricuspid valve (TV) intervention at the time of left-sided heart valve surgery were high at the time of mitral valve surgery (50% when mitral stenosis, 41% when MR). An increase in TR grade was associated with a more severe clinical presentation and a poorer 6-month survival ( p  < 0.0001).

Tricuspid 40

Tricuspid Heart Disease Bicuspid/Mitral Heart Valves 40

DAIC

DECEMBER 26, 2023

The potential to detect aortic stenosis through our IH technology is an exciting development that brings us a step closer to achieving the MindMics purpose to one day eliminate heart failure as the leading cause of death globally (similar to what glucose monitoring has done to transform diabetes)." "We

Stenosis 59

Stenosis Technology Aortic Aortic valve 59

DAIC

APRIL 9, 2024

The other half of participants received the balloon-expandable SAPIEN valve, which is made from bovine tissue and inserted inside the heart valve by using a balloon to expand to full size. of patients who received the Evolut valve and 10.6% of those receiving the SAPIEN valve.

TAVR 59

TAVR Aortic valve Aortic Anatomy 59

DAIC

MARCH 4, 2025

22, 2025More than 60,000 people die from heart valve disease (HVD) in the U.S. each year, according to the American Heart Association 2025 Heart Disease and Stroke Statistical Update. This year on Heart Valve Disease Awareness Day (Feb. tim.hodson Tue, 03/04/2025 - 14:11 Feb.

Heart Valves 52

Heart Valves Aortic valve Aortic Stenosis 52

DAIC

FEBRUARY 15, 2024

Advances in Transcatheter Tricuspid Valve Technologies VIDEO: Tricuspid Device Clinical Trial Overview — Interview with Ori Ben-Yehuda, M.D.

Tricuspid 102

Tricuspid Heart Valves Quality of Life Bicuspid/Mitral 102

DAIC

APRIL 2, 2024

Food and Drug Administration (FDA) approval of its TriClip, a first-of-its-kind device to repair leaky tricuspid heart valve, for which more than 1.6 TR occurs when the valve doesn't close properly, causing a leak and allowing blood to flow backward in the heart. Abbott has announced U.S million people in the U.S.

Tricuspid 105

Tricuspid Heart Valves Quality of Life Open-Heart Surgery 105

DAIC

DECEMBER 22, 2023

Tricuspid regurgitation (TR) is a common and serious disease for which open heart surgery and symptomatic pharmacologic treatment are the current standard treatment options. To date, a total of 24 Topaz implantations have been performed across Europe and Canada.

Tricuspid 59

Tricuspid Pacemaker Heart Valves Open-Heart Surgery 59

Hypertension Journal

MARCH 1, 2024

By these mechanisms, SMC-MR promotes disease progression in models of aging-associated vascular stiffness, vascular calcification, mitral and aortic valve disease, pulmonary hypertension, and heart failure. While rarely tested, when sexes were compared, the mechanisms of SMC-MR-mediated disease were sexually dimorphic.

Blood Pressure 40

Blood Pressure Aortic valve Heart Failure Hypertension 40

Stroke Journal

JANUARY 30, 2025

The NOAC exclusion group were more likely to have medical co-morbidities including Afib/Aflutter, prosthetic heart valves, CAD/prior MI, heart failure, prior DVT/PE and sleep apnea (Table 1). Both groups had an equal probability of having a history of a previous stroke.

Thrombolysis 40

Thrombolysis Strokes Stroke AFIB 40

Society of Thoracic Surgeons - Research

APRIL 20, 2023

Adult Cardiac Surgery Database Lead Author Title Publication Date Jacob Raphael Red Blood Cell Transfusion and Pulmonary Complications: The Society of Thoracic Surgeons Adult Cardiac Surgery Database Analysis The Annals of Thoracic Surgery January 2024 Joseph Sabik Multi-Arterial versus Single-Arterial Coronary Surgery: Ten Year Follow-up of One Million (..)

Research 52

Research Coronary Artery Bypass Graft Aortic valve Congenital 52

Society of Thoracic Surgeons - Research

APRIL 20, 2023

Program Designations Access and Publications (A&P) 1 Participant User File (PUF) 2 Task Force on Funded Research (TFR) 3 Special Projects 4 Adult Cardiac Surgery Database Lead Author Title Publication Date William Keeling 2 National Trends in Emergency Coronary Artery Bypass Grafting European Journal of Cardiothoracic Surgery October 2023 Jake (..)

Research 52

Research Coronary Artery Bypass Graft Aortic valve Congenital 52

DAIC

FEBRUARY 18, 2025

Raj Makkar, MD: Tricuspid regurgitation is a condition where the tricuspid valve fails to close properly, allowing blood to flow backward into the right atrium. How has treatment for tricuspid valve disease evolved?

Tricuspid 52

Tricuspid Open-Heart Surgery Quality of Life Anatomy 52